Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19

BACKGROUND: Emerging data support detectable immune responses for months after severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and vaccination, but it is not yet established to what degree and for how long protection against reinfection lasts. METHODS: We investigated SARS‐CoV...

Descripción completa

Detalles Bibliográficos
Autores principales: Havervall, Sebastian, Ng, Henry, Jernbom Falk, August, Greilert‐Norin, Nina, Månberg, Anna, Marking, Ulrika, Laurén, Ida, Gabrielsson, Lena, Salomonsson, Ann‐Christin, Aguilera, Katherina, Kihlgren, Martha, Månsson, Maja, Rosell, Axel, Hellström, Cecilia, Andersson, Eni, Olofsson, Jennie, Skoglund, Lovisa, Yousef, Jamil, Pin, Elisa, Lord, Martin, Åberg, Mikael, Hedhammar, My, Tegel, Hanna, Dönnes, Pierre, Phillipson, Mia, Nilsson, Peter, Klingström, Jonas, Mangsbo, Sara, Hober, Sophia, Thålin, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661920/
https://www.ncbi.nlm.nih.gov/pubmed/34459525
http://dx.doi.org/10.1111/joim.13387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661920/
https://www.ncbi.nlm.nih.gov/pubmed/34459525
http://dx.doi.org/10.1111/joim.13387

Ejemplares similares